Elissa Joy Charbonneau
Known title: Chief Medical OfficerCIK: 0001647458
Associated companies
Transaction History
| EHC | ▼ Sell | Tax Withholding | 369 | $40K | 2/28/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 440 | $47K | 2/23/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 287 | $31K | 2/20/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 4,016 | $430K | 2/19/2026 | View on chart |
| EHC | ▲ Buy | Grant | 1,884 | $0 | 2/19/2026 | View on chart |
| EHC | ▲ Buy | Grant | 8,914 | $0 | 2/18/2026 | View on chart |
| EHC | ▼ Sell | Open Market | 4,279 | $499K | 5/6/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 364 | $36K | 2/28/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 506 | $51K | 2/25/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 435 | $42K | 2/24/2025 | View on chart |
| EHC | ▲ Buy | Grant | 1,939 | $0 | 2/20/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 2,991 | $276K | 1/1/2025 | View on chart |
| EHC | ▼ Sell | Open Market | 10,000 | $850K | 5/24/2024 | View on chart |
| EHC | ▲ Buy | Grant | 2,489 | $0 | 2/28/2024 | View on chart |
| EHC | ▲ Buy | Grant | 6,601 | $0 | 2/28/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 506 | $38K | 2/25/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 356 | $27K | 2/24/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 434 | $33K | 2/23/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 2,281 | $152K | 1/2/2024 | View on chart |
| EHC | ▼ Sell | Open Market | 8,294 | $577K | 8/17/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 506 | $30K | 2/27/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 356 | $21K | 2/24/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,972 | $0 | 2/23/2023 | View on chart |
| EHC | ▲ Buy | Grant | 4,909 | $0 | 2/23/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 332 | $21K | 2/21/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 1,477 | $88K | 1/3/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,872 | $0 | 2/25/2022 | View on chart |
| EHC | ▲ Buy | Grant | 2,534 | $0 | 2/25/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 296 | $19K | 2/24/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 604 | $40K | 2/22/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 1,206 | $79K | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.